Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer

被引：0
|
作者：
Andrew Dodson
David Okonji
Laura Assersohn
Anne Rigg
Amna Sheri
Nick Turner
Ian Smith
Marina Parton
Mitch Dowsett
机构：
[1] The Royal Marsden Hospital NHS Foundation Trust,Ralph Lauren Centre for Breast Cancer Research
[2] Institute of Cancer Research,Breast Unit
[3] The Royal Marsden Hospital NHS Foundation Trust,undefined
[4] St George’s University Hospitals NHS Foundation Trust,undefined
[5] Guy’s and St Thomas’ Hospitals NHS Foundation Trust,undefined
[6] Royal Free London Hospitals NHS Foundation Trust,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 168卷
关键词：
Breast cancer; Oncotype DX; Recurrence score; RSPC, prognosis; Recurrence risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：249 / 258
页数：9
相关论文
共 50 条
  • [1] Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
    Dodson, Andrew
    Okonji, David
    Assersohn, Laura
    Rigg, Anne
    Sheri, Amna
    Turner, Nick
    Smith, Ian
    Parton, Marina
    Dowsett, Mitch
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 249 - 258
  • [2] Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer
    Bloom, J. A.
    Sekigami, Y.
    Cao, Y.
    Buchsbaum, R. J.
    Naber, S. P.
    Chatterjee, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S51 - S51
  • [3] Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer
    Joshua A. Bloom
    Yurie Sekigami
    Rebekah Young
    Lisa Macera
    Christy A. Russell
    Yu Cao
    Rachel J. Buchsbaum
    Stephen P. Naber
    Abhishek Chatterjee
    [J]. Annals of Surgical Oncology, 2021, 28 : 8711 - 8716
  • [4] Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer
    Wang, Fei
    Reid, Sonya
    Zheng, Wei
    Pal, Tuya
    Meszoely, Ingrid
    Mayer, Ingrid A.
    Bailey, Christina E.
    Park, Ben Ho
    Shu, Xiao-Ou
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (01) : 101 - 109
  • [5] Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer
    Bloom, Joshua A.
    Sekigami, Yurie
    Young, Rebekah
    Macera, Lisa
    Russell, Christy A.
    Cao, Yu
    Buchsbaum, Rachel J.
    Naber, Stephen P.
    Chatterjee, Abhishek
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8711 - 8716
  • [6] A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score
    Bowles, Daniel W.
    Rabinovitch, Rachel
    Borges, Virginia
    Urquhart, Alexander
    Singh, Meenakshi
    Finlayson, Christina
    Elias, Anthony
    [J]. ONCOLOGY-NEW YORK, 2007, 21 (10): : 1212 - 1217
  • [7] Predicting late recurrence in ER-positive breast cancer
    Jack Cuzick
    [J]. Nature Reviews Clinical Oncology, 2019, 16 : 406 - 408
  • [8] Predicting late recurrence in ER-positive breast cancer
    Cuzick, Jack
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 406 - 408
  • [9] The impact of the Oncotype DX recurrence score pathology-clinical (RSPC) on the predicted recurrence risk for node negative breast cancer patients: A cancer center experience
    Wexelman, Barbara A.
    Gallagher, Alexander
    Smith, Barbara L.
    Isakoff, Steven J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy
    Pece, Salvatore
    Sestak, Ivana
    Montani, Francesca
    Tillhon, Micol
    Maisonneuve, Patrick
    Freddi, Stefano
    Chu, Kim
    Colleoni, Marco
    Veronesi, Paolo
    Disalvatore, Davide
    Viale, Giuseppe
    Buus, Richard
    Cuzick, Jack
    Dowsett, Mitch
    Di Fiore, Pier Paolo
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 164 : 52 - 61
12345